Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab vs Mycophenolate Mofetil in Children with Steroid-Dependent Nephrotic Syndrome
NCT05843968Phase 2Recruiting
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Jan 2023
- Primary completion
- Jul 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in nephrotic syndrome, sponsored by Children's Hospital of Chongqing Medical University. Started Jan 2023; status: recruiting.
02
Drugs
rituximab
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT05843968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05843968.